Biblio Discovery — Demo Discovery Service

8 results for "Jeremy Cheng"

Showing 1–8 · 0.21 seconds · RSS

  1. Journal Article

    Describing the not criminally responsible population in Alberta’s history: Sociodemographic, mental health, and criminological profiles

    Andrew M. Haag; Jeremy Cheng; Robi Wirove

    Journal of Community Safety and Well-Being, Vol. 1 No. 3 · 2016 · English · DOAJ

    This is the first paper to look at the entire population of those found Not Criminally Responsible on Account of Mental Disorder (NCR) in Alberta, Canada. The Alberta NCR Project examined longitudinal data from the NCR population to describe sociodemographic, mental health, and criminological…

  2. Journal Article

    Historical recidivism rates of Alberta’s not criminally responsible population

    Kayla Richer; Jeremy Cheng; Andrew M. Haag

    Journal of Community Safety and Well-Being, Vol. 3 No. 2 · 2018 · English · DOAJ

    In Canada, public safety is a paramount concern for the provincial Review Boards that oversee individuals found to be Not Criminally Responsible on Account of Mental Disorder (NCR). There is limited research on recidivism rates for NCR populations to assist public policy and institutional…

  3. Journal Article Full text

    Cystolitholapaxy Without Transurethral Resection of the Prostate: Clinical Outcomes and Predictors of Subsequent Resection

    Jeremy Cheng; Arjun Guduguntla; Arveen Kalapara et al.

    Société Internationale d’Urologie Journal, Vol. 6 No. 6 · 2025 · English · DOAJ

    Background/Objectives: Limited data exist on the outcomes of men with bladder stones undergoing cystolitholapaxy alone versus cystolitholapaxy with concurrent transurethral resection of the prostate (TURP). Additionally, factors associated with the need for subsequent TURP in these patients are not…

  4. Journal Article Full text

    Features and Management of Incidental Prostatic Lymphoma Obtained in Lower Urinary Tract Symptoms Surgery: A Systematic Review

    Jeremy Cheng; Samith Minu Alwis; Nathan Papa et al.

    Société Internationale d’Urologie Journal, Vol. 6 No. 2 · 2025 · English · DOAJ

    Background/Objectives: Prostatic lymphoma is a rare malignant tumour that frequently causes urinary tract obstruction. It is uncommon for patients to present with systemic features or B-symptoms. As a result, it is often diagnosed incidentally during surgical lower urinary tract symptoms (LUTS)…

  5. Journal Article

    Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?

    Jeremy Cheng; Mohammadmehdi Adhami; Tho Pham et al.

    BJUI Compass, Vol. 6 No. 4 · 2025 · English · DOAJ Scopus

    Abstract Objectives To evaluate the relationship between total lesion PSMA (PSMATL), serum PSA, histopathological findings and biochemical recurrence (BCR) in patients with localised prostate cancer (PCa). Patients and methods This retrospective study assessed men undergoing 68Ga‐PSMA‐11 PET/CT for…

  6. Journal Article

    High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneouslyResearch in context

    Yong Gu; Zhiyuan Zhao; Kathleen Waugh et al.

    EBioMedicine, Vol. 47 · 2019 · English · DOAJ Scopus

    Background: Islet autoantibodies (IAbs) are the most reliable biomarkers to assess risk of progression to clinical type 1 diabetes (T1D). There are four major biochemically defined IAbs currently used in clinical trials that are equally important for disease prediction. The current screening…

  7. Journal Article

    Functional outcomes and toxicity following focal low‐dose‐rate brachytherapy for low–intermediate risk prostate cancer

    Mohammadmehdi Adhami; Jeremy Cheng; Elliot Anderson et al.

    BJUI Compass, Vol. 7 No. 2 · 2026 · English · DOAJ Scopus

    Abstract Objectives We aim to prospectively evaluate functional outcomes and toxicity following focal low‐dose‐rate (LDR) brachytherapy for low–intermediate risk prostate cancer (PCa). Patients and Methods LIBERATE is a clinical registry of men treated with focal LDR brachytherapy for…

  8. Journal Article

    Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer

    Mohammadmehdi Adhami; Jeremy Cheng; Elliot Anderson et al.

    BJUI Compass, Vol. 7 No. 2 · 2026 · English · DOAJ Scopus

    Abstract Objectives To prospectively evaluate oncological control, pathological progression, and its predictors following focal low‐dose‐rate (LDR) brachytherapy for low‐intermediate risk prostate cancer (PCa). Patients and methods LIBERATE is a prospective, multi‐centre clinical registry of…